Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinoma

被引:20
|
作者
Saro, Junichiro [2 ]
Fujiwara, Masachika [3 ]
Kawakami, Tomohiro [4 ]
Sumiishi, Ayumi [3 ]
Sakata, Seiji [3 ]
Sakamoto, Atsuhiko [3 ]
Kurata, Atsushi [1 ]
机构
[1] Tokyo Med Univ, Dept Mol Pathol, Shinjuku Ku, Tokyo 1608402, Japan
[2] Kyorin Univ Hosp, Tokyo, Japan
[3] Kyorin Univ, Sch Med, Dept Pathol, Tokyo, Japan
[4] Juntendo Univ, Urayasu Hosp, Chiba, Japan
关键词
thymoma; immunohistochemistry; fascin; dendritic cell; tumor immunity; DIFFERENTIATION; DISEASE; CANCER;
D O I
10.3892/ol.2011.383
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The majority of thymomas are histologically characterized by tumor-infiltrating lymphocytes. Mature dendritic cells (DCs) are known to assemble lymphocytes through antigen presentation to T lymphocytes. Fascin, a 55-kDa actin-binding protein and a known marker for mature DCs, regulates filaments necessary for the formation of filopodia in cell migration. Moreover, fascin expression in various epithelial neoplasms has recently been reported to be associated with invasion of tumor cells and clinically aggressive manifestations. In the present study, we investigated fascin expression immunohistochemically in tissues of thymomas and thymic carcinomas surgically resected at our institute. A total of 34 thymomas and 5 thymic carcinomas were included. The amount and immunohistochemical intensity of both fascin(+) DCs and tumor epithelium were counted and assessed, and the clinicopathological data were also scored. Statistical analyses revealed that the amount of fascin+ DCs with the formation of clusters was associated with lymphocyte-rich variants (p=0.002) and cortical differentiation (p=0.037) of thymoma with complication from myasthenia gravis (p=0.002). The quantity of fascin+ epithelium was associated with a strong intensity of fascin in infiltrating DCs (p=0.002) with the formation of clusters (p=0.002) and favorable prognosis, as assessed by the Masaoka staging system (p=0.001). The amount of infiltrating DCs (p=0.024) and fascin(+) epithelium were lower in thymic carcinoma. It was concluded that fascin+ epithelium may induce tumor immunity through the surveillance activity of fascin(+) DCs in thymic neoplasms, thus improving prognosis.
引用
收藏
页码:1025 / 1032
页数:8
相关论文
共 50 条
  • [1] The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma
    Li, Huiyang
    Ren, Bo
    Yu, Shili
    Gao, Hongwen
    Sun, Ping-Li
    BMC CANCER, 2023, 23 (01)
  • [2] The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma
    Huiyang Li
    Bo Ren
    Shili Yu
    Hongwen Gao
    Ping-Li Sun
    BMC Cancer, 23
  • [3] Thymoma and thymic carcinoma
    Venuta F.
    Rendina E.A.
    Anile M.
    De Giacomo T.
    Vitolo D.
    Coloni G.F.
    General Thoracic and Cardiovascular Surgery, 2012, 60 (1) : 1 - 12
  • [4] Thymoma and thymic carcinoma
    Marx, A
    Müller-Hermelink, HK
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (06) : 739 - 740
  • [5] Thymoma and thymic carcinoma
    Jain, Satinder Kumar
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 40 (06) : 658 - 659
  • [6] Thymoma and thymic carcinoma
    Venuta, Federico
    Anile, Marco
    Diso, Daniele
    Vitolo, Domenico
    Rendina, Erino A.
    De Giacomo, Tiziano
    Francioni, Federico
    Coloni, Giorgio Furio
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 37 (01) : 13 - 25
  • [7] Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States
    Hsu, Chun-Hsiang
    Chan, John K.
    Yin, Chun-Hao
    Lee, Ching-Chih
    Chern, Chyi-Uei
    Liao, Cheng-, I
    PLOS ONE, 2019, 14 (12):
  • [8] Thymic epithelium supports the generation of human thymic dendritic cells.
    Gasparetto, M
    Miralles, GD
    Patel, D
    Gasparetto, C
    Fernandez-Casal, M
    Morse, M
    Smith, C
    BLOOD, 1999, 94 (10) : 127B - 127B
  • [9] Effects of UVB on fascin expression in dendritic cells and Langerhans cells
    Sugihara, A
    Okamoto, H
    Horio, T
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2005, 40 (03) : 177 - 185
  • [10] Therapy of thymoma and thymic carcinoma
    Ried M.
    Rechenmacher M.
    Dietl B.
    Marx A.
    Hamer O.W.
    Schalke B.
    Kirzinger L.
    Hofmann H.-S.
    best practice onkologie, 2017, 12 (5) : 206 - 214